Combined hepatitis B core-related antigen and surface antigen levels predict hepatocellular carcinoma development in patients treated with nucleos(t)ide analogues

被引：0
|
作者：
Hosaka, Tetsuya [1 ]
Suzuki, Fumitaka [1 ]
Kobayashi, Masahiro [1 ]
Fujiyama, Shunichiro [1 ]
Kunimoto, Hideo [1 ]
Sorin, Yushi [1 ]
Kawamura, Yusuke [1 ]
Sezaki, Hitomi [1 ]
Akuta, Norio [1 ]
Suzuki, Yoshiyuki [1 ]
Saitoh, Satoshi [1 ]
Arase, Yasuji [1 ]
Ikeda, Kenji [1 ]
Kobayashi, Mariko [2 ]
Kumada, Hiromitsu [1 ]
机构：
[1] Toranomon Gen Hosp, Hepatol, Tokyo, Japan
[2] Toranomon Gen Hosp, Res Inst Hepatol, Kawasaki, Kanagawa, Japan
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2020
引用
收藏
页码：1193A / 1194A
页数：2
相关论文
共 50 条
  • [1] Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fujiyama, Shunichirou
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (04) : 457 - 471
  • [2] The development of HCC in chronic hepatitis B patients with nucleos (t)ide analogs: Focus on hepatitis B surface antigen and core-related antigen
    Ozeki, Itaru
    Suii, Hirokazu
    Tatsumi, Ryoji
    Yamaguchi, Masakatsu
    Kimura, Mutsuumi
    Arakawa, Tomohiro
    Nakajima, Tomoaki
    Kuwata, Yasuaki
    Ohmura, Takumi
    Hige, Shuhei
    Karino, Yoshiyasu
    Toyota, Joji
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E477 - E477
  • [3] Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues (vol 49, pg 457, 2019)
    Hosaka, T.
    Suzuki, F.
    Kobayashi, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (02) : 234 - 235
  • [4] Letter: impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues-further clarifications needed
    Lim, Miao-Shan
    Tan, Chee-Kiat
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (02) : 232 - 232
  • [5] A risk score combining quantitative hepatitis B surface antigen and core-related antigen levels to predict off-therapy relapse after cessation of nucleos(t)ide analogues in patients with chronic hepatitis B
    Hsu, Y. -C.
    Tanaka, Y.
    Nguyen, M.
    Chang, C. -Y.
    Tai, C. -M.
    Tseng, C. -H.
    Chen, C. -C.
    Wu, M. -S.
    Lin, J. -T.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S498 - S498
  • [6] Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues
    Chen, Chien-Hung
    Chiu, Yi-Chun
    Lu, Sheng-Nan
    Lee, Chuan-Mo
    Wang, Jing-Houng
    Hu, Tsung-Hui
    Hung, Chao-Hung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (24) : 7686 - 7695
  • [7] Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues
    Alidjinou, Enagnon K.
    Michel, Charlotte
    Canva, Valerie
    Ajana, Faiza
    Hober, Didier
    Bocket, Laurence
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (05) : 989 - 993
  • [8] Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues
    Chien-Hung Chen
    Yi-Chun Chiu
    Sheng-Nan Lu
    Chuan-Mo Lee
    Jing-Houng Wang
    Tsung-Hui Hu
    Chao-Hung Hung
    World Journal of Gastroenterology, 2014, (24) : 7686 - 7695
  • [9] Letter: impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues-further clarifications needed. Authors' reply
    Hosaka, Tetsuya
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (02) : 233 - 233
  • [10] Relationship between hepatitis B core related antigen levels and sustained HBeAg seroconversion in patients treated with nucleos (t)ide analogues
    Sonneveld, Milan
    Oord, Gertine
    van Campenhout, Margo J. H.
    De Man, Robert
    Janssen, Harry
    De Knegt, Robert
    Van der Eijk, Annemiek
    Boonstra, Andre
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E484 - E484
12345